A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more youthful state has officially begun. This week, the United States ...

Washington — The Justice Department on Tuesday accused the Equal Employment Opportunity Commission of violating federal civil rights laws by issuing guidelines that effectively pressured employers to ...

Anthropic has released Claude Fable 5, the first publicly available version of its closely watched Mythos model. What can Fable actually do? All kinds of things, it turns out. Ethan Mollick, a notable ...

Add Yahoo as a preferred source to see more of our stories on Google. (Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the clock' ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

Water from the hose made the big enamel pan ring with a sound that said another night’s work was done. It had been a good day on the lake and ...

An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more youthful state has officially begun. This week, the United States ...

Life Biosciences began the first human trial of partial cellular reprogramming for aging reversal The experimental ER-100 therapy targets glaucoma and age-related optic nerve damage ER-100 uses gene ...